Introduction {#s0001}
============

Both hyperglycemia and glycemic fluctuation are frequently seen in the perioperative period and increase the risk of acute kidney injury (AKI) as described in the literature \[[@CIT0001]\]. The mechanism of kidney functional damage is caused by exposure to transient hyperglycemia, most likely secondary to increased oxidative stress generated through the xanthine pathway observed in animal studies \[[@CIT0002],[@CIT0003]\]. Acute hyperglycemia leads to increased urinary excretion of inflammatory cytokines/chemokines in humans with diabetes \[[@CIT0004]\] or nondiabetes \[[@CIT0005]\] and may directly contribute to kidney injury. Wider glycemic fluctuation is known to trigger inflammation to a higher degree than sustained hyperglycemia, leading to greater oxidative stress tissue damage \[[@CIT0006],[@CIT0007]\].

The association between poor intraoperative glycemic control and postoperative AKI in cardiac surgery has been observed; intraoperative mean glucose \>200 mg/dl was associated with increased renal morbidity \[[@CIT0008]\], intraoperative mean glucose \>180 mg/dl \[[@CIT0009]\] or \>150 mg/dl \[[@CIT0010]\] was independently associated with AKI, maximal intraoperative glucose was associated with AKI \[[@CIT0011]\] and glycemic variability was a predictor of AKI \[[@CIT0009]\]. However, the results of interventional studies comparing tight or liberal blood glucose control in cardiac surgery conflict; tight blood glucose control (80--110 mg/dl) could reduce renal impairment \[[@CIT0005],[@CIT0012]\] or not \[[@CIT0011],[@CIT0013]\]. All of the abovementioned studies were adult samples and pediatric research has been very limited. Most congenital heart disease pediatric patients do not have diabetes or renal disease history, and lower age babies' immature kidneys may make the results different from adults. Recently, Joshua's \[[@CIT0014]\] study showed that AKI pediatric patients after cardiac surgery had a large proportion of the highest intraoperative glucose \>250 mg/dl. Furthermore, Andrew's \[[@CIT0015]\] study found that postoperative peak glucose in the cardiac intensive care unit (cICU) was associated with pediatric patients' postoperative renal insufficiency, but the intraoperative peak glucose levels were not associated with postoperative renal insufficiency. However, the effect of intraoperative glycemic fluctuation was not addressed in the two studies. The association between how well intraoperative glycemic levels are controlled and postoperative renal function in children undergoing cardiac surgery is unclear. We performed a retrospective study to test the hypothesis that intraoperative hyperglycemia and/or wider glycemic fluctuation was associated with the incidence of postoperative AKI in pediatric cardiac surgery.

Materials and methods {#s0002}
=====================

Study population {#s0003}
----------------

After the study was approved by our hospital research committee, we reviewed hospital medical records, nursing records, the laboratory database, and the cardiac surgical database. Informed consent was waived because the study was a retrospective analysis. In total, 1026 pediatric patients (\<18 years old) who underwent surgery for congenital heart disease from 1 January 2013, through 31 December 2016 were eligible for the analysis. Patients were excluded if they had: 1. preoperative kidney dysfunction or a history of renal/diabetic disease; 2. preoperative massive transfusion or nephrotoxic drug usage; 3. preoperative serious infection. Additionally, children were excluded if the daily medical record was incomplete, especially incomplete blood glycemic data less than 4 or incomplete sCr data less than 2 during the perioperative period. Furthermore, patients were excluded if their only operation did not involve cardiopulmonary bypass (CPB).

Data acquisition {#s0004}
----------------

Researchers collected intraoperative glycemic data before, during, and after CPB and postoperative glycemic data up to 48 h after surgery. In this study, *initial glycemic level* (iG) is the first glycemic concentration measured during surgery but before CPB; *mean glycemic level* (mG) refers to the average of all perioperative glycemic levels for an individual; *peak glycemic level* (pG) is the highest glycemic level attained during surgery for each patient. The magnitude of *intraoperative glycemic fluctuation* (intraGF) was defined as the standard difference (SD) of each patient's mean intraoperative glycemic level \[[@CIT0016]\]. Patients were subdivided into three groups based on the magnitude of glycemic fluctuation: Group A: 0 to \<36 mg/dl; Group B: ≥36 to 72 mg/dl; Group C: ≥72 mg/dl.

Pediatric AKI was defined according to a modified version of the Acute Kidney Injury Network (AKIN) criteria \[[@CIT0017]\]. In brief, patients in this study were classified as having AKI if they had an increase in sCr to 1.5 times or more of their baseline within the first 48 h after the operation or to 26.5 μmol/L or more in the first 48 h after the operation. The severity stages are defined as follows: AKIN I, 1.5∼\<2-fold baseline sCr；AKIN II, ≥2∼\<3-fold baseline sCr；AKIN III, ≥3-fold baseline sCr. A patient's baseline sCr was recorded during the hospitalization preceding the operation, and peak sCr was recorded within 48 h after the operation. We did not use the urine criteria in AKIN; urine output data that used retrospective ascertainment, including calculating the interval changes, would have a risk for inaccuracy.

All patients were cared by the same team of anesthesiologists, surgeons, perfusionists, and intensivists. Surgical complexity was assessed using the Risk Adjustment in Congenital Heart Surgery (RACHS)-1 score \[[@CIT0018]\] because this was the most common case-mix adjustment method that was used when the trial protocol was developed. The details of anesthesia and the surgical procedure itself were reported previously \[[@CIT0019]\]. Anesthesia was induced with intravenous midazolam and vecuronium bromide, followed by intravenous fentanyl and intermittent inhaled isoflurane to maintain anesthesia. A median sternal incision was made, and defects were repaired under CPB. Myocardial protection was achieved by intermittent perfusion of 4:1 cold blood cardioplegia or total cold crystalloid cardioplegia (custodial solution). CPB was performed using a pediatric hollow fiber oxygenator, circuits and a roller pump with nonpulsatile flow for both groups. Activated clotting time was maintained above 480 s, the perfusion flow was given at 80--150 mL/kg, the diluted hematocrit at 20--25% (neonates 30%) was gained by conventional priming program, and mild-to-moderate hypothermic (27--34 °C) was maintained during CPB. When necessary, hypo-perfusion flow (less than half of the targeted flow) or deep hypothermic circulation arrest (DHCA), multiple occlusion of the aorta (OA), and ultrafiltration were used during CPB period. After defect repairs were completed, rewarming started and ceased at a nasopharyngeal temperature of 37.0 °C and rectal temperature above 35.0 °C . Postoperatively, all patients were transported while they were intubated to the cICU. The postoperative inotropic score (IS ~POD~) refers to all the inotropic drugs used from the heart rebeating time point to the postoperative 48 h and was calculated using the formula: (dopamine + dobutamine) × 1 +milrinone ×15 + (adrenaline + noradrenaline + isoproterenol) × 100. RBC ~POD0-2~ refers to red blood cells (RBC) transfusion within postoperative 48 h, and Others ~POD0-2~ refers to plasma(u)+platelet(u)+ cryoprecipitate(u) transfusion within postoperative 48 h. Fluid overload in the postoperative period was calculated by the formula: \[total fluid administration (L) - total fluid output (L)\]/basic weight(kg); results \>5% were recorded \[[@CIT0020]\].

Short-term outcomes that were evaluated included duration of postoperative mechanical ventilation (MV), length of cICU stay, hospital stay, renal replacement therapy (RRT: refer to postoperative peritoneal dialysis, blood dialysis or continuous blood purification) and mortality during hospitalization.

Statistical analyses {#s0005}
--------------------

A Chi-square test was used for categorical variables that were summarized as frequencies and percentages. Continuous variables were expressed as the mean ± SD, and the *t*-test was used when data was normally distributed. The Mann--Whitney U-test was used when the data were non-normally distributed, and data were expressed as medians (IQR). To generate two evenly matched cohorts of patients who did and did not experience AKI, we propensity-scored children by using the following pre- and intra-operative variables: sex, age, weight, cyanosis, RACHS-1 score, preoperative left ventricular ejection fraction (LVEF), CPB time, OA time, iG, and baseline sCr. In the detection of 118 cases who had AKI, we matched 111 AKI patients with 111 control patients who underwent surgery during the same time period. The remaining seven cases had no suitable propensity scores. Variables associated with AKI with a *p* values \<0.1 were then manually entered into a conditional logistic regression model to find the independent risk factors. The three groups of glycemic fluctuation and AKI severity stage were analyzed for linear trends. A *p* values \<.05 was considered significant. Data analysis was performed using SPSS 23.0 statistical software (SPSS Inc., Chicago, IL).

Results {#s0006}
=======

During four years, the incidence of AKI was 11.5% (118/1026) in our pediatric cardiac surgery center. Of those with AKI, 53.4% (63/118), 30.5% (36/118), and 16.1% (19/118) were categorized as AKIN stages I, II, and III, respectively. The patients' perioperative characteristics are shown in [Table 1](#t0001){ref-type="table"}; diseases included but were not limited to tetralogy of Fallot with/without atrial septal defect, pulmonary atresia, anomalous pulmonary veins drainage, endocardial cushion defect, transposition of the great arteries, coronary artery fistula, aorta-pulmonary window, atrioventricular canal malformation, persistent truncus arteriosus, single ventricle or atrium, hypoplastic or interrupted aortic arch, and Ebstein or other valve anomalies. Before matching, the entire sample who experienced AKI were younger and cyanotic, had a higher RACHS-1 score, and less preoperative LVEF (all *p* \< .01) when compared with those who did not experience AKI. They also underwent CPB for a longer time, longer OA time, more frequency of multiple OA, ultrafiltration, DHCA or hypoperfusion (all *p* \< .01) during surgery. They had higher mG, pG, intraGF, IS ~POD~, and more transfusions during the perioperative period (all *p* \< .01).

###### 

Patient perioperative characteristics and short-term outcomes with and without acute kidney injury in the entire sample and in the matched sample.

                                                   Entire sample   Matched sample                                                                 
  ------------------------------------------------ --------------- ---------------- ---------- ------ --------------- ---------------- ---------- ------
  Male sex \[*n* (%)\]                             465 (51.2)      59 (50)          0.061      .804   53 (47.8)       58 (52.2)        0.649      .421
  Age at surgery (mo), median (IQR)                36 (12,72)      12 (4,45)        (−5.726)   .000   12 (6,36)       13 (4,48)        (−0.139)   .889
  Age ≤2 mo \[*n* (%)\]                            37 (4.1)        15 (12.7)        16.191     .000   20 (18.0)       13 (11.7)        1.744      .187
  Weight (kg), median (IQR)                        13 (9,20)       8 (5,14.1)       (-6.169)   .000   8.5 (6.5,13)    8.5 (5.2,14.6)   (-0.440)   .660
  Cyanotic \[*n* (%)\]                             65 (7.2)        53 (44.9)        40.195     .000   50 (45.0)       47 (42.3)        0.165      .685
  RACHS-1 score \[*n* (%)\]                                                         136.667    .000                                    1.778      .777
   1                                               91 (10.0)       1 (0.8)                            1 (0.9)         1 (0.9)                      
   2                                               577 (63.5)      34 (28.9)                          38 (34.2)       35 (31.5)                    
   3                                               190 (21.0)      44 (37.3)                          44 (39.6)       43 (38.8)                    
   4                                               43 (4.7)        36 (30.5)                          25 (22.6)       31 (27.9)                    
   5                                               7 (0.8)         3 (2.5)                            3 (2.7)         1 (0.9)                      
  Preoperative LVEF \<50% \[*n* (%)\]              225 (24.8)      52 (44.1)        19.712     .000   54 (48.6)       50 (45.0)        0.289      .591
  Baseline sCr                                     43 (39,50)      41 (34,46)       (−1.083)   .279   42 (38,49)      41 (35,46)       (−0.974)   .330
  CPB time (min), (x ± s )                         72 ± 34         131 ± 83         (−7.665)   .000   110 ± 49        126 ± 82         (−1.718)   .087
  OA time (min), (x ± s )                          44 ± 26         77 ± 47          (−7.543)   .000   68 ± 29         75 ± 47          (−1.514)   .132
  Multiple OA \[*n* (%)\]                          14 (1.5)        15 (12.7)        47.438     .000   9 (8.1)         13 (11.7)        0.807      .369
  Ultrafiltration \[*n* (%)\]                      591 (65.1)      110 (93.2)       38.188     .000   102 (91.9)      100 (90.1)       0.220      .639
  DHCA or hypoperfusion \[*n* (%)\]                17 (1.9)        15 (12.7)        40.608     .000   8 (7.2)         7 (6.3)          0.071      .789
  iG (mg/dl), (x ± s )                             86 ± 17         87 ± 20          (−0.965)   .335   92 ± 20         88 ± 20          (1.158)    .248
  mG(mg/dl), (x ± s )                              106 ± 25        124 ± 20         (−5.181)   .000   126 ± 30        126 ± 25         (0.170)    .865
  pG(mg/dl), median (IQR)                          134 (105,178)   163 (139,217)    (−5.758)   .000   162 (137,216)   162 (140,216)    (−0.695)   .487
  IntraGF(mg/dl), median (IQR)                     22 (13,38)      45 (25,76)       (−8.300)   .000   36 (20,63)      49 (25,81)       (−2.376)   .018
  IS ~POD~, median (IQR)                           1(0,8)          7 (2,11)         (−6.269)   .000   2 (1,10)        7 (1,16)         (−2.961)   .003
  Peak sCr                                         49 (42,56)      80 (64,110)      (−4.368)   .000   50 (43,55)      79 (65,112)      (−4.206)   .000
  Transfusion: RBC ~POD0-2~ (u), median (IQR)      0.5 (0,1.5)     1 (0,2.5)        (−5.234)   .000   0.5 (0,1.5)     1 (0,2)          (−2.540)   .011
  Transfusion: Others ~POD0-2~ (u), median (IQR)   0.5 (0,4)       2 (0,5)          (−4.102)   .000   2 (0,6)         2 (0,5)          (−0.647)   .518
   FO~POD1~                                        105 (11.6)      16 (13.6)        0.400      .527   10 (9%)         15 (13.5%)       1.127      .288
   FO~POD2~                                        91 (10.0)       12 (10.2)        0.002      .963   14 (12.6%)      11 (9.9%)        0.406      .524
  Short-term outcomes                                                                                                                              
   Postoperative RRT \[*n* (%)\]                   3 (0.3)         15 (12.7)        92.881     .000   0 (0)           13 (11.7)        13.809     .000
   Length of MV(h), median (IQR)                   14 (6,28)       36 (13,73)       (−5.925)   .000   15 (7,26)       34 (14,76)       (−4.257)   .000
   Length of cICU stay(h), median (IQR)            70 (28,154)     119 (68,240)     (−5.145)   .000   68 (38,149)     157 (72,226)     (−4.857)   .000
   Length of hospital stay(d), median (IQR)        12 (9,16)       15 (13,20)       (−6.921)   .000   12 (10,16)      16 (13,20)       (−4.991)   .000
   Mortality \[*n* (%)\]                           7 (0.8)         18 (15.3)        92.146     .000   0 (0)           15 (13.5)        16.087     .000

AKI: acute kidney injury; cICU: cardiac intensive care unit; CPB: cardiopulmonary bypass; DHCA: deep hypothermic circulation arrest; FO~POD1~: Fluid overload \>5% within postoperative 24 h; FO~POD2~: Fluid overload \>5% within postoperative 24--48 h; iG: initial glycemic level; intraGF: intraoperative glycemic fluctuation; IS~POD~: inotropic score to the postoperative 48 h; LVEF: left ventricular ejection fraction; MV: mechanical ventilation; mG: mean glycemic level; OA: occlusion of aorta; Others ~POD0-2~: plasma(u)+platelet(u)+ cryoprecipitate(u) transfusion within postoperative 48 h; pG: peak glycemic level; RACHS-1: Risk Adjustment in Congenital Heart Surgery; RBC ~POD0-2~: red blood cells transfusion within postoperative 48 h; RRT: renal replacement therapy; sCr: serum Creatinine.

The matched group set included 111 pairs of children with and without AKI. As illustrated in [Table 1](#t0001){ref-type="table"}, the matched groups were balanced for the variables of demographic data, preoperative renal function, glycemic level, and preoperative and intraoperative cardiac condition. Compared with the entire sample, there Iwere no significant difference in pG or mG between the matched samples, but a significant difference was observed in intraGF, IS ~POD~, and RBC ~POD0-2~ transfusion between patients with AKI and those without AKI. Whether matched or not, the matched sample and the entire sample who had AKI had poor short-term outcomes including longer lengths of MV, cICU stay, hospital stay, as well as higher RRT and mortality (all *p* \< .01).

The conditional logistic regression test showed intraGF (*p* = .033) and IS ~POD~ (*p* = .031) were independent risk factors for AKI within the matched sample set ([Table 2](#t0002){ref-type="table"}). The linear trend test ([Figure 1](#F0001){ref-type="fig"}) showed that the degree of AKI severity stage increased when the glycemic fluctuation increased; two were linear (Trend value 76.698, *p* = .000).

![Intraoperative glycemic fluctuation and postoperatvie AKI (linear trend, *p* = .000). AKI: acute kidney injury; AKIN: acute kidney injury network.](IRNF_A_1532908_F0001_C){#F0001}

###### 

Multivariate conditional logistic regression analysis of perioperative risk factors associated with AKI.

  Variables                   95%CI   HR      *p*     
  --------------------------- ------- ------- ------- ------
  IntraGF                     1.008   1.213   1.106   .033
  IS ~POD~                    1.002   1.052   1.027   .031
  Transfusion: RBC ~POD0-2~   0.959   1.106   1.030   .417
  CPB time                    0.999   1.004   1.001   .224

CPB: cardiopulmonary bypass; intraGF: intraoperative glycemic fluctuation; IS~POD~: inotropic score to the postoperative 48 h; RBC~POD0-2~: red blood cells transfusion within postoperative 48 h.

Discussion {#s0007}
==========

Our study showed that wider intraGF was associated with postoperative AKI in pediatric cardiac CPB surgery. There was no association between perioperative mG or pG and postoperative AKI.

Our results demonstrated that the postoperative AKI incidence of cardiac surgery was 11.5%, consistent with a previous finding of 10--45% based on AKIN criteria \[[@CIT0016],[@CIT0021]\]. The 1.8% rate of requiring RRT is consistent with the 1--5% that was previously reported \[[@CIT0022]\]. Potential preoperative and intraoperative factors contributing to the difference in AKI frequency \[[@CIT0023]\], such as younger age, small body size, higher RACHS-1 score and CPB strategy were matched 1:1 by the propensity score between patients who had AKI and those who did not. We found that patients with AKI still had higher intraGF after propensity matching the above variables.

The current consensus regarding glycemic control in the critically ill is that strict glycemic control is not beneficial and may even be harmful \[[@CIT0024]\]. Glycemic fluctuation in critically ill patients has recently gained interest and has repeatedly been shown to be associated with adverse outcomes \[[@CIT0025]\]. It is increasingly recognized that acute glycemic variability is a more specific trigger of oxidative stress, when compared with chronic sustained hyperglycemia states. Glycemic fluctuation increases AKI risk in adult patients undergoing coronary artery bypass graft surgery \[[@CIT0026]\], but data in pediatric patients remain unknown. However, our study suggested that children who underwent cardiac surgery with more intraoperative glycemic fluctuation were more likely to develop postoperative AKI compared with patients who had less intraoperative glycemic fluctuation. Furthermore, the degree of AKI severity stage increased when glycemic fluctuation increased. The association between glycemic fluctuation and AKI can be explained by a plausible biological explanation \[[@CIT0006],[@CIT0007]\] that intermittent hyperglycemia causes more oxidative stress in endothelial cells compared to constant hyperglycemia and induces a greater over-production of reactive oxygen species by NADPH. Krinsley's study \[[@CIT0027]\] showed that nondiabetics were less tolerant to acute glycemic fluctuation because of their lack of chronic exposure to these variabilities. Bansal's study \[[@CIT0009]\] showed that glycemic fluctuation was a predictor of an increase in creatinine and AKI after cardiac surgery. Although there is currently insufficient evidence to ascertain the mechanism of this phenomenon, our data strengthened this finding.

There are some negative findings in our study. Fluid overload is known \[[@CIT0027],[@CIT0028]\] as a risk factor that is associated with AKI incidence and degree, hospital duration and mortality. Even mild fluid overload is an independent risk factor for the incidence of AKI \[[@CIT0029]\]. Our results did not find a significant difference between fluid overload (\>5%) and AKI incidence within 48-h postoperation ([Table 1](#t0001){ref-type="table"}), most likely because most of our patients underwent intraoperative ultrafiltration (entire sample \>65% while matched sample \>90%) and ultrafiltration-related volume depletion modified postoperative fluid overload to a certain extent. DHCA or hypoperfusion in CPB \[[@CIT0030],[@CIT0031]\] is another risk factor of postoperative AKI in some animal and human studies, especially in adult aortic surgeries \[[@CIT0032],[@CIT0033]\]. However, our results showed no significant difference of DHCA and AKI incidence; a plausible explanation is that DHCA incidence (6--7% in matched pairs) is not large enough to have a significant difference and other CPB strategies (such as hypothermia, sufficient oxygen supply, slowly and equably rewarming) protect kidney function.

Our study has a number of limitations. First, it is a retrospective single-center observational study, and information bias should be considered. A prospective study is warranted to confirm our results. Second, intermittent measurements of glycemia and sCr 48 h perioperatively may have underestimated hyperglycemia or AKI incidence. Third, drugs that affect renal function or glycemic level (such as antibiotics, diuretics and insulin) that were administered were not included in the analysis. Fourth, the study comprised patients of different ages with heterogeneous congenital heart defects; this increases the heterogeneity but improves the generalizability of the study. We balanced the heterogeneity of patient and operation characteristics with propensity score matching.

Conclusions {#s0008}
===========

In our retrospective single-center observational study, wider intraoperative glycemic fluctuation, but not hyperglycemia, seems to be associated with an increased incidence of postoperative AKI after pediatric cardiac surgery. Further prospective trials are mandated to confirm the association found in our study.
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